India Plans To Sell Generic Cancer, CV Drugs At Hefty Discounts
This article was originally published in PharmAsia News
Executive Summary
India has announced a pilot scheme to sell hundreds of generic cancer and cardiovascular drugs, as well as cardiac implants, at levels at least 50% below normal retail prices through government-run outlets, in a drive to make important medicines more affordable to its vast population.